Anaplastic Oligodendroglioma

Showing NaN - NaN of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

Recruiting
  • Glioblastoma Multiforme
  • +5 more
  • Los Angeles, California
  • +12 more
Jan 9, 2023

Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Los Angeles, California
  • +11 more
Jul 1, 2022

Anaplastic Oligodendroglioma, Oligoastrocytoma, Oligodendroglioma Trial in Los Angeles (Wear novoTTF-200A, Quality-of-Life

Withdrawn
  • Anaplastic Oligodendroglioma
  • +2 more
  • Wear novoTTF-200A
  • Quality-of-Life Assessment
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Dec 8, 2020

Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (Toca 511, Toca FC)

Completed
  • Glioblastoma Multiforme
  • +3 more
  • Toca 511
  • Toca FC
  • Irvine, California
  • +5 more
May 16, 2018

Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (Toca 511 vector, Toca FC)

Completed
  • Glioblastoma Multiforme
  • +3 more
  • Toca 511 vector
  • Toca FC
  • Los Angeles, California
  • +7 more
May 16, 2018

Teratoid Tumor, Atypical, Choroid Plexus Tumors, Anaplastic Astrocytoma Trial in United States (azurin-derived cell-penetrating

Completed
  • Teratoid Tumor, Atypical
  • +9 more
  • azurin-derived cell-penetrating peptide p28
  • Los Angeles, California
  • +10 more
Aug 3, 2017

Gliomas, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Los Angeles (alloreactive CTL)

Completed
  • Gliomas
  • +5 more
  • alloreactive CTL
  • Los Angeles, California
    University of California, Los Angeles
May 26, 2016